Free Trial
LON:SCLP

Scancell (SCLP) Share Price, News & Analysis

Scancell logo
GBX 9.90 +0.03 (+0.25%)
As of 09:54 AM Eastern

About Scancell Stock (LON:SCLP)

Key Stats

Today's Range
9.55
9.90
50-Day Range
8.02
12
52-Week Range
7.26
19.75
Volume
69,367 shs
Average Volume
894,515 shs
Market Capitalization
£102.54 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Scancell (LSE:SCLP) is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers. Scancell has developed a pipeline of ‘off-the-shelf’ vaccines to induce immune responses and highly tumour specific monoclonal antibodies to redirect immune cells or drugs. Our advanced therapeutic vaccine programmes, SCOPE and ModiFY, have shown promising efficacy in Phase 2 trials, demonstrating long-term survival in metastatic melanoma and a broad range of solid tumours.

Receive SCLP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Scancell and its competitors with MarketBeat's FREE daily newsletter.

SCLP Stock News Headlines

Gold is soaring. Here’s how to get paid from it
Gold just broke through $3,300… And while the headlines shout about price targets, something even more powerful is happening behind the scenes… Some investors are using a little-known ETF to collect up to $1,152/month from gold's surge. No trading gold futures. No mining stocks. No vaults. Just a simple fund delivering monthly payouts — like clockwork.
Scancell Hldgs Plc (SCLP)
Scancell Holdings Secures £11.3 Million in Oversubscribed Offering
See More Headlines

SCLP Stock Analysis - Frequently Asked Questions

Scancell's stock was trading at GBX 10.85 at the start of the year. Since then, SCLP stock has decreased by 8.8% and is now trading at GBX 9.90.
View the best growth stocks for 2025 here
.

Scancell Holdings plc (LON:SCLP) released its quarterly earnings results on Thursday, January, 30th. The company reported ($1.35) earnings per share for the quarter.

Shares of SCLP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Scancell investors own include KAZ Minerals (KAZ), Petropavlovsk (POG), Standard Chartered (STAN), AorTech International (AOR), Ascential (ASCL), Advanced Oncotherapy (AVO) and Empyrean Energy (EME).

Company Calendar

Last Earnings
1/30/2025
Today
6/13/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
LON:SCLP
CIK
N/A
Fax
N/A
Employees
51
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£6.75 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
GBX 1.26 per share
Price / Cash Flow
7.86
Book Value
GBX (0.39) per share
Price / Book
-25.40

Miscellaneous

Outstanding Shares
1,035,724,932
Free Float
N/A
Market Cap
£102.54 million
Optionable
Not Optionable
Beta
0.35
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (LON:SCLP) was last updated on 6/13/2025 by MarketBeat.com Staff
From Our Partners